Cargando…
Surgical management and perioperative morbidity of patients with primary borderline ovarian tumor (BOT)
BACKGROUND: Surgery is the cornerstone for clinical management of patients with borderline ovarian tumors (BOT). As these patients have an excellent overall prognosis, perioperative morbidity is the critical point for decision making when the treatment strategy is developed and the primary surgical...
Autores principales: | Trillsch, Fabian, Ruetzel, Jan David, Herwig, Uwe, Doerste, Ulrike, Woelber, Linn, Grimm, Donata, Choschzick, Matthias, Jaenicke, Fritz, Mahner, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708757/ https://www.ncbi.nlm.nih.gov/pubmed/23837881 http://dx.doi.org/10.1186/1757-2215-6-48 |
Ejemplares similares
-
Diagnostic workup for endometrioid borderline ovarian tumors (eBOT) requires histopathological evaluation of the uterus
por: Reichenbach, Juliane, et al.
Publicado: (2021) -
Beyond Bevacizumab: An Outlook to New Anti-Angiogenics for the Treatment of Ovarian Cancer
por: Mahner, Sven, et al.
Publicado: (2015) -
Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer
por: Woelber, Linn, et al.
Publicado: (2011) -
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study
por: Trillsch, F, et al.
Publicado: (2015) -
Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer
por: Prieske, Katharina, et al.
Publicado: (2017)